cisplatin

You have access
First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective Study
JIAN-RI LI, SHIAN-SHIANG WANG, KEVIN LU, CHAUN-SHU CHEN, CHEN-LI CHENG, SHENG-CHUN HUNG, KUN-YUAN CHIU, CHIANN YI HSU and CHENG-KUANG YANG

Anticancer Research March 2023, 43 (3) 1331-1339; DOI: https://doi.org/10.21873/anticanres.16281
You have access
Simultaneously Integrated Boost Affects Survival in Locally Advanced p16-Negative Oropharyngeal Squamous Cell Carcinoma
FRANCESCA DE FELICE, DANIELA MUSIO, MARIA SERPONE, GIANMARCO VAVALLE, CLAUDIA MARCHETTI and VINCENZO TOMBOLINI

Anticancer Research December 2022, 42 (12) 5909-5915; DOI: https://doi.org/10.21873/anticanres.16100
Open Access
Hyperthermic Intraperitoneal Chemotherapy in the Management of Primary Epithelial Ovarian Cancer: A Debated Issue for Gynecologic Oncologists
ANGIOLO GADDUCCI, STEFANIA COSIO and PIERO VINCENZO LIPPOLIS

Anticancer Research October 2022, 42 (10) 4659-4665; DOI: https://doi.org/10.21873/anticanres.15970
You have access
Additional Effects of Docetaxel on Neoadjuvant Radiotherapy With Cisplatin/5-Fluorouracil for Esophageal Squamous Cell Carcinoma
KEN SASAKI, YUSUKE TSURUDA, MASATAKA SHIMONOSONO, MASAHIRO NODA, YASUTO UCHIKADO, TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, SHINICHIRO MORI, AKIHIRO NAKAJO, HIROSHI KURAHARA and TAKAO OHTSUKA

Anticancer Research August 2022, 42 (8) 3905-3911; DOI: https://doi.org/10.21873/anticanres.15884
You have access
Comparative Proteomic Profiling of Cisplatin-resistant Nasopharyngeal Carcinoma Cell Lines: Novel Biomarkers for Improving Chemotherapy of NPC
PARISA PRATHAPHAN, ONRAPAK REAMTONG, UTAPIN NGAOKRAJANG, TAVAN JANVILISRI, NAPACHANOK MONGKOLDHUMRONGKUL SWAINSON and PICHAMON KIATWUTHINON

Anticancer Research July 2022, 42 (7) 3507-3522; DOI: https://doi.org/10.21873/anticanres.15837
You have access
Hearing Loss After Cisplatin-based Chemoradiotherapy for Locally Advanced Head and Neck Cancer: A Prospective Single-institution Study
DANIELA MUSIO, MARCO DE VINCENTIIS, PASQUALINA D’URSO, ANGELA MUSACCHIO, VERONICA MAIURI, LUCY ZACCARO, MASSIMO RALLI, CLAUDIA MARCHETTI, ROSARIA TURCHETTA, VINCENZO TOMBOLINI and FRANCESCA DE FELICE

Anticancer Research June 2022, 42 (6) 3003-3009; DOI: https://doi.org/10.21873/anticanres.15784
You have access
Control and Risk Factors of Nausea and Vomiting in Patients With Cervical Cancer Receiving Radiotherapy
AKANE UNO, SENRI YAMAMOTO, HIROTOSHI IIHARA, HIRONORI FUJII, CHIYOKO MAKITA, YOH HAYASAKI, YUKINO UEDA, MASAYA ITO, MOTOKI TAKENAKA, TOMOYASU KUMANO, MINAKO MORI, MOEKA YASUE, HIROKO KATO-HAYASHI, RYO KOBAYASHI, KEN-ICHIROU MORISHIGE, MASAYUKI MATSUO, HIDEKI HAYASHI and AKIO SUZUKI

Anticancer Research June 2022, 42 (6) 3117-3123; DOI: https://doi.org/10.21873/anticanres.15800
You have access
Suitability of Oral Rehydration Solution (ORS) for Use in the Cisplatin Short Hydration Method
YOSHITAKA SAITO, YOH TAKEKUMA, MASAKI KOBAYASHI, NAOFUMI SHINAGAWA, TAKURO NOGUCHI, SATOSHI TAKEUCHI, YASUSHI SHIMIZU, ICHIRO KINOSHITA, HIROTOSHI DOSAKA-AKITA and MITSURU SUGAWARA

Anticancer Research June 2022, 42 (6) 3185-3193; DOI: https://doi.org/10.21873/anticanres.15808
Open Access
Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial
TAKASHI YOSHIOKA, MASANOBU TAKAHASHI, YASUHIRO SAKAMOTO, AKIRA OKITA, TADAHISA FUKUI, YASUKO MURAKAWA, YOSHIAKI SHINDO, HIROO IMAI, HISATSUGU OHORI, HIDEKAZU SHIROTA, NATSUKO CHIBA, YURIKO (ITO) SASAHARA, TAKASHI NOMURA, NORIMASA FUKUSHIMA, TAKUHIRO YAMAGUCHI, HIDEKI SHIMODAIRA and CHIKASHI ISHIOKA

Anticancer Research April 2022, 42 (4) 2009-2015; DOI: https://doi.org/10.21873/anticanres.15680
You have access
Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells
SAE HAMAYA, SHINTARO FUJIHARA, HISAKAZU IWAMA, KOJI FUJITA, TINGTING SHI, RYOTA NAKABAYASHI, TAKAAKI MIZUO, KEI TAKUMA, MAI NAKAHARA, KYOKO OURA, TOMOKO TADOKORO, SHIMA MIMURA, JOJI TANI, ASAHIRO MORISHITA, HIDEKI KOBARA, MASAFUMI ONO, TAKASHI HIMOTO and TSUTOMU MASAKI

Anticancer Research March 2022, 42 (3) 1263-1275; DOI: https://doi.org/10.21873/anticanres.15593

Main menu

User menu

Search

cisplatin

Pages